{"data":{"type":"company_profile","id":148895,"entity_id":"wefunder:company:148895","attributes":{"canonical_url":"https://wefunder.com/ventoux.biosciences","generated_at":"2026-07-22T23:45:34Z","updated_at":"2026-07-21T23:54:16Z","entity_ids":{"company":"wefunder:company:148895","slug":"wefunder:company_slug:ventoux.biosciences"},"profile_visibility":{"owner_published":true,"public_search_results":true,"site_search_listed":true,"privacy_mode":"promote","invite_only":false},"provenance":{"source":"wefunder_public_company_profile","as_of":"2026-07-22T23:45:34Z","claims":{"total_amount_raised":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-07-21T23:54:16Z","as_of":"2026-07-22T23:45:34Z","confidence":"high"},"total_investors":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-07-21T23:54:16Z","as_of":"2026-07-22T23:45:34Z","confidence":"high"},"active_raise_states":{"source":"Fundraise.visible(nil, nil)","last_verified_at":"2026-07-02T19:11:52Z","as_of":"2026-07-22T23:45:34Z","confidence":"high"},"latest_fundraise_state":{"source":"Fundraise.visible(nil, nil).order(funding_started_at)","last_verified_at":"2026-07-02T19:11:52Z","as_of":"2026-07-22T23:45:34Z","confidence":"medium"}}},"company":{"id":148895,"entity_id":"wefunder:company:148895","slug":"ventoux.biosciences","name":"Ventoux Biosciences","tagline":"Modulating Fibrosis, Restoring Function ","location":"Encinitas, CA","website":"VentouxBio.com","total_amount_raised":0,"total_investors":0,"is_funded":false,"is_active":false,"quality_score":3,"related_urls":["https://wefunder.com/ventoux.biosciences","VentouxBio.com"]},"media":{"share_image_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/148895/xxl_blob.jpg","logo_url":"https://uploads.wefunder.com/uploads/company/logo/148895/large_blob","header_media_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/148895/standard_blob.jpg","cover_photo_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/148895/standard_blob.jpg"},"links":{"company_url":"VentouxBio.com","linkedin_url":"https://linkedin.com/company/Ventoux-Biosciences","facebook_url":"https://facebook.com/VentouxBio","instagram_url":"https://instagram.com/VentouxBio","youtube_url":"https://youtube.com/@VentouxBio","blog_url":"https://handsofchange.podbean.com/"},"highlights":[],"quick_facts":[{"index":1,"claim_id":"claim-fact-1","value":"Founded by a Dupuytren's patient to transform care for millions with immune-fibrotic diseases"},{"index":2,"claim_id":"claim-fact-2","value":"Targeting Dupuytren's and Spinal Cord Injury with VEN-201, a novel, immune-fibrotic modulator"},{"index":3,"claim_id":"claim-fact-3","value":"VEN-201 rebalances the immune system to reduce fibrosis and activate repair"},{"index":4,"claim_id":"claim-fact-4","value":"2025 Pre-Clinical Biopharmaceutical Company of the Year Winner, by GHP Biotechnology Awards"},{"index":5,"claim_id":"claim-fact-5","value":"$4.3B Dupuytren's disease market, \u0026gt;3x larger than Rheumatoid Arthritis - no approved treatments"},{"index":6,"claim_id":"claim-fact-6","value":"SCI: ~$10B annually, VEN-201 targets fibrosis, addressing the key market opportunity in recovery"},{"index":7,"claim_id":"claim-fact-7","value":"Strong IP: Broad immune-fibrotic patent to 2044, global filings plus key provisional filings"}],"team":[{"id":4058078,"entity_id":"wefunder:company_role:4058078","user_entity_id":"wefunder:user:4189790","role":"founder","name":"Kurt Harrington","title":"Founder, CEO","bio":"\u0026gt;25 years of biotechnology and pharmaceutical operational and commercial leadership, early stage product development, launch, and in-market optimization Expertise in specialty markets including immunology, pain/ inflammation, fibrosis, and surgery.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/4058078/square_blob.jpg?1766416524","profile_url":"https://wefunder.com/kurt.harrington","personal_url":"https://ventouxbio.com","related_urls":["https://wefunder.com/kurt.harrington","https://ventouxbio.com"]},{"id":4249704,"entity_id":"wefunder:company_role:4249704","user_entity_id":"wefunder:user:3840571","role":"employee","name":"Kenneth Lipson","title":"Chief Scientific Officer, VP Corporate Strategy","bio":"Highly accomplished research leader in fibrosis and cancer target validation, drug discovery, and translational research. Dr. Lipson's work is represented in over 100 publications in peer-reviewed journals, review articles, book chapters, and patent app","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/4249704/square_blob.jpg?1766416524","profile_url":"https://wefunder.com/kenneth.lipson","related_urls":["https://wefunder.com/kenneth.lipson"]},{"id":5440226,"entity_id":"wefunder:company_role:5440226","role":"employee","name":"Laxma Reddy","title":"VP, Product Development ","bio":"Dr. Laxma Reddy is the Vice President of Product Development for Ventoux Biosciences. Dr. Reddy is a biochemist, protein chemist, and pharmaceutical development scientist with \u0026gt;30 years of experience in drug discovery, preclinical development, and sustain","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5440226/square_blob.jpg?1766416524","related_urls":[]}],"featured_investors":[{"id":12434,"entity_id":"wefunder:company_investor_profile:12434","investor_profile_id":4390844,"investor_profile_entity_id":"wefunder:investor_profile:4390844","subject_entity_id":"wefunder:user:4899398","name":"Johnny Randel","role_title":"","bio":"Johnny Randel is a retired CFO with more than 30 years of experience in financial institutions including over 17 in private equity.","avatar_url":"https://wefunder.com/rails/active_storage/blobs/redirect/eyJfcmFpbHMiOnsiZGF0YSI6NjQwMTYwLCJwdXIiOiJibG9iX2lkIn19--bcce536efb7e27745bc06a96c31d2444f9a2788b/filename","profile_url":"https://wefunder.com/johnny.randel.1","endorsement_quote":"Ventoux is a founder-led biotech with a purpose and a mission that I strongly support. Kurt’s personal journey gives Ventoux an unmatched focus and sense of urgency. From an investor perspective, I was drawn to the blend of a a clear clinical strategy and initial evidence combined with the personal insight of a lived experience. Kurt and Ventoux are developing a platform that will be a game-changer and provide solutions for many people. I am in!","endorsement_name":"","investment_total":100000,"investment_info":"Invested $70,000 this round \u0026 $30,000 previously","is_lead_investor":true,"related_urls":["https://wefunder.com/johnny.randel.1"]}],"investor_memos":[],"tab_counts":{"posts":0,"ask_questions":0,"featured_investors":1,"faq_entries":0},"active_fundraises":[{"id":104663,"entity_id":"wefunder:fundraise:104663","state":"open","offering_type":"4(a)(6)","funding_type":"note","structure":"ttw","security_type":"","currency":"USD","testing_the_waters":true,"min_purchase":100,"max_purchase":9,"funding_target":124000.0,"minimum_target":"50000.0","maximum_target":"124000.0"}],"latest_fundraise":{"id":104663,"entity_id":"wefunder:fundraise:104663","state":"open","offering_type":"4(a)(6)","structure":"ttw","testing_the_waters":true,"can_invest_now":true,"funding_started_at":null,"funding_closed_at":null,"terms":{"eb":null,"nb":"$13M","txt":"valuation cap"}},"recent_posts":[],"q_and_a":[],"faq":[]}}}